carnitine has been researched along with Hyperlipoproteinemia in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study was designed to investigate the effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein (CRP), Lp (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia [hyper Lp (a)]." | 9.14 | Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia. ( Hedayati, M; Shakeri, A; Tabibi, H, 2010) |
| " In order to investigate the influence of L(--)-carnitine on hyperlipoproteinemias, the experimental model of the sucrose-induced hypertriglyceridemia of the rat was used." | 7.67 | Carnitine and experimental carbohydrate-induced hyperlipoproteinemia. ( Löster, H; Rassoul, F; Richter, V; Rotzsch, W; Schulz, G; Seim, H; Sittner, WD, 1987) |
| " The present study was designed to investigate the effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein (CRP), Lp (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia [hyper Lp (a)]." | 5.14 | Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia. ( Hedayati, M; Shakeri, A; Tabibi, H, 2010) |
| " In order to investigate the influence of L(--)-carnitine on hyperlipoproteinemias, the experimental model of the sucrose-induced hypertriglyceridemia of the rat was used." | 3.67 | Carnitine and experimental carbohydrate-induced hyperlipoproteinemia. ( Löster, H; Rassoul, F; Richter, V; Rotzsch, W; Schulz, G; Seim, H; Sittner, WD, 1987) |
| "Simvastatin was administered, in both groups, at a dosage of 20 mg/day, while l-carnitine was administered at a dosage of 2g/day once daily." | 2.72 | Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus. ( Capurso, A; Capurso, C; Capurso, SA; Colacicco, AM; D'Introno, A; Fontana, C; Gadaleta, AM; Koverech, A; Panza, F; Solfrizzi, V; Torres, F, 2006) |
| "A mouse with juvenile visceral steatosis (the JVS mouse) has been recognized as a novel animal model for systemic carnitine deficiency." | 1.29 | Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency. ( Fujimura, H; Hanafusa, T; Kuwajima, M; Miyagawa, J; Narama, I; Ono, A; Oue, T; Ozaki, K; Uenaka, R; Yamamoto, K, 1995) |
| " The recommended dosage of clofibrate is 1." | 1.26 | [Fat and renal failure--therapeutic aspects]. ( Heidland, A; Hörl, M; Hörl, WH, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (66.67) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shakeri, A | 1 |
| Tabibi, H | 1 |
| Hedayati, M | 1 |
| Solfrizzi, V | 1 |
| Capurso, C | 1 |
| Colacicco, AM | 1 |
| D'Introno, A | 1 |
| Fontana, C | 1 |
| Capurso, SA | 1 |
| Torres, F | 1 |
| Gadaleta, AM | 1 |
| Koverech, A | 1 |
| Capurso, A | 1 |
| Panza, F | 1 |
| Hörl, WH | 2 |
| Hörl, M | 2 |
| Heidland, A | 2 |
| Druml, W | 1 |
| Laggner, A | 1 |
| Lenz, K | 1 |
| Balcke, P | 1 |
| Kleinberger, G | 1 |
| Schmidt, P | 1 |
| Giorcelli, G | 1 |
| Vacha, G | 1 |
| Icardi, GP | 1 |
| Gusmano, R | 1 |
| Oleggini, R | 1 |
| Perfumo, F | 1 |
| Miyagawa, J | 1 |
| Kuwajima, M | 1 |
| Hanafusa, T | 1 |
| Ozaki, K | 1 |
| Fujimura, H | 1 |
| Ono, A | 1 |
| Uenaka, R | 1 |
| Narama, I | 1 |
| Oue, T | 1 |
| Yamamoto, K | 1 |
| Richter, V | 1 |
| Rassoul, F | 1 |
| Schulz, G | 1 |
| Sittner, WD | 1 |
| Seim, H | 1 |
| Löster, H | 1 |
| Rotzsch, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for carnitine and Hyperlipoproteinemia
| Article | Year |
|---|---|
[Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].
Topics: Adrenergic beta-Antagonists; Carnitine; Cholesterol; Cholesterol, HDL; Diuretics; Humans; Hyperlipop | 1982 |
2 trials available for carnitine and Hyperlipoproteinemia
| Article | Year |
|---|---|
Effects of L-carnitine supplement on serum inflammatory cytokines, C-reactive protein, lipoprotein (a), and oxidative stress in hemodialysis patients with Lp (a) hyperlipoproteinemia.
Topics: Adult; Aged; Aged, 80 and over; C-Reactive Protein; Carnitine; Cytokines; Dietary Supplements; Femal | 2010 |
Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
Topics: Aged; Apolipoproteins B; Carnitine; Cholesterol; Diabetes Mellitus, Type 2; Drug Therapy, Combinatio | 2006 |
6 other studies available for carnitine and Hyperlipoproteinemia
| Article | Year |
|---|---|
[Lipid metabolism and lipid utilization in renal failure].
Topics: Acute Kidney Injury; Carnitine; Cholesterol; Energy Metabolism; Fat Emulsions, Intravenous; Humans; | 1983 |
[Fat and renal failure--therapeutic aspects].
Topics: Acute Kidney Injury; Animals; Bezafibrate; Carnitine; Charcoal; Clofibrate; Clofibric Acid; Humans; | 1982 |
Drug treatment of hypertriglyceridaemia in chronic uraemic patients: preliminary report on D,L-carnitine and thiadenol.
Topics: Carnitine; Chronic Disease; Clofibrate; Fatty Alcohols; Humans; Hyperlipoproteinemias; Lipid Metabol | 1980 |
Plasma carnitine concentrations and dyslipidemia in children on maintenance hemodialysis.
Topics: Carnitine; Child; Child, Preschool; Humans; Hyperlipoproteinemias; Kidney Failure, Chronic; Lipids; | 1981 |
Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency.
Topics: Animals; Carnitine; Fatty Liver; Hyperlipoproteinemias; Mice; Mice, Mutant Strains; Microscopy, Elec | 1995 |
Carnitine and experimental carbohydrate-induced hyperlipoproteinemia.
Topics: Animals; Carnitine; Cholesterol; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Hyperlip | 1987 |